CVE-2021-29045: Cross-site scripting (XSS) vulnerability in the Redirect module's redirection administration page in Lifera...
Cross-site scripting (XSS) vulnerability in the Redirect module's redirection administration page in Liferay Portal 7.3.2 through 7.3.5, and Liferay DXP 7.3 before fix pack 1 allows remote attackers to inject arbitrary web script or HTML via the _com_liferay_redirect_web_internal_portlet_RedirectPortlet_destinationURL parameter.
Security readout for executives and security teams
Plain-English summary
This vulnerability is an XSS issue in Liferay’s Redirect administration page. An attacker could inject script or HTML through a destination URL parameter. The public bundle names affected Liferay Portal 7.3.2 through 7.3.5 and Liferay DXP 7.3 before fix pack 1.
Executive priority
Treat this as a targeted remediation item for affected Liferay environments, not a broad emergency. Prioritize systems with exposed administration interfaces or high-value authenticated users.
Technical view
CVE-2021-29045 affects the Redirect module redirection administration page. The vulnerable parameter is _com_liferay_redirect_web_internal_portlet_RedirectPortlet_destinationURL, which may accept attacker-controlled script or HTML. No CVSS, CWE, or exploit details were provided in the bundle.
Likely exposure
Exposure is likely limited to organizations running the named Liferay Portal or DXP versions, especially where the Redirect administration function is reachable by untrusted or compromised users.
Exploitation context
The bundle describes remote injection of arbitrary web script or HTML, but does not provide evidence of active exploitation. The CVE is not marked as CISA KEV in the supplied data.
Researcher notes
Evidence is sparse: the bundle provides affected versions, vulnerable component, parameter, and vendor reference, but no CVSS, CWE, PoC, or exploitation confirmation. Avoid assuming impact beyond XSS without vendor details.
Mitigation direction
Identify Liferay Portal and DXP versions in use.
Apply Liferay’s relevant fixed release or DXP 7.3 fix pack 1 or later.
Follow the linked Liferay advisory for product-specific remediation details.
Restrict administrative access to trusted users while remediation is pending.
Validation and detection
Confirm no production instance runs Liferay Portal 7.3.2 through 7.3.5.
Confirm Liferay DXP 7.3 instances have fix pack 1 or later.
Review Redirect administration access for unexpected users or changes.
Check the vendor advisory for any version-specific notes.
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Potential ATT&CK relevance
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
cve · low confidence lookup
CVE-2021-29045 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
0CVSS vectors
3Timeline events
1ADP providers
2Source links
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
CVE publishedCVE Program
The CVE record was published.
May 17, 2021, 10:22 UTC (UTC+00:00)
CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.